# AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs

> **NCT06320184** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 650 (actual)

## Conditions studied

- Lung Cancer
- Blood Biomarkers

## Interventions

- **DIAGNOSTIC_TEST:** Artificial Intelligence risk model

## Key facts

- **NCT ID:** NCT06320184
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-30
- **Primary completion:** 2024-10-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06320184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06320184, "AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06320184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*